Equibles does not estimate personal net worth.
Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMRX alertsAnastasios (Tasos) G. Konidaris is recorded as CFO at Amneal Pharmaceuticals, Inc. (AMRX) since March 12, 2020. Anastasios (Tasos) G. Konidaris has spoken on 1 earnings call across 1 company, most recently for Amneal Pharmaceuticals, Inc. on February 27, 2026. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.
“The fourth quarter completed another terrific year for MNIL with strong top and bottom line growth as Q4 revenues grew 11%, adjusted EBITDA grew 13%, and adjusted EPS grew 75%.”
2020-03-12–present
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2020-03-12–present
